Trials / Completed
CompletedNCT04431687
A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)
A Randomized, Open-label, 2-Part, Multiple-dose, Two-way Crossover Clinical Trial to Evaluate Drug-drug Interactions and Safety Between CKD-501, D759, and D150 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D759 and D150
Detailed description
A Randomized, Open-label, 2-Part, Multiple-dose, Two-way Crossover Clinical Trial to Evaluate Drug-drug Interactions and safety between CKD-501, D759, and D150 in Healthy Adult
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD 501 | QD, PO |
| DRUG | D759, D150 | QD, PO |
| DRUG | CKD-501, D759, D150 | QD, PO |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2020-07-24
- Completion
- 2020-10-26
- First posted
- 2020-06-16
- Last updated
- 2020-11-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04431687. Inclusion in this directory is not an endorsement.